Dose‐range and dose‐frequency study of recombinant human interleukin‐1 receptor antagonist in patients with rheumatoid arthritis

Objective. To preliminarily evaluate the safety and efficacy of different dose levels and dosing frequencies of recombinant human interleukin‐1 receptor antagonist (rHuIL‐1Ra) in the treatment of patients with rheumatoid arthritis (RA). Methods. One hundred seventy‐five patients with active RA were...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Arthritis and rheumatism 1996-07, Vol.39 (7), p.1092-1101
Hauptverfasser:	Campion, G. V., Lebsack, M. E., Lookabaugh, J., Gordon, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Diseases of the osteoarticular system Inflammatory joint diseases Medical sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!